[90] In March 2026, the CHMP recommended granting a conditional marketing authorization for Kayshild (semaglutide), a GLP-1 receptor agonist for the treatment of non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with liver fibrosis, a serious disease where fat deposits accumulate in the liver causing inflammation
Thyroid Cancer Much has been written and spoken about the potential risk for thyroid cancer in individuals taking GLP-1s
Look for transparency, clear contact information, and professional accreditations
Glutathione injections, when used the right way, can be a valuable part of your skin care journey
For diabetes, if youre open to injections, Ozempic may be an option and may have different coverage or savings programs
That battle is playing out in courthouses and statehouses, as well, including in Indiana, where lawmakers appear poised to pass legislation regulating compound pharmacies